id
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
list | ner_tags
list |
|---|---|---|---|---|---|
NCT02531711
|
1:22:chronic_disease
|
Cognitive dysfunction preventing informed consent
| 1
|
[
"Cognitive",
"dysfunction",
"preventing",
"informed",
"consent"
] |
[
2,
2,
0,
0,
0
] |
NCT02323880
|
58:64:cancer,98:116:treatment,128:132:cancer,137:156:cancer,,,,,271:280:treatment,300:307:treatment
|
Part C: Patients with recurrent or refractory high grade glioma (WHO grade III/IV) and requiring surgical resection (excluding DIPG and disseminated tumors), who in the opinion of treating physicians, are medically stable to receive 3-4 doses of selinexor (8-10 days of treatment) before undergoing surgery without compromising the success of the procedure
| 1
|
[
"Part",
"C",
":",
"Patients",
"with",
"recurrent",
"or",
"refractory",
"high",
"grade",
"glioma",
"(",
"WHO",
"grade",
"III/IV",
")",
"and",
"requiring",
"surgical",
"resection",
"(",
"excluding",
"DIPG",
"and",
"disseminated",
"tumors",
")",
",",
"who",
"in",
"the",
"opinion",
"of",
"treating",
"physicians",
",",
"are",
"medically",
"stable",
"to",
"receive",
"3-4",
"doses",
"of",
"selinexor",
"(",
"8-10",
"days",
"of",
"treatment",
")",
"before",
"undergoing",
"surgery",
"without",
"compromising",
"the",
"success",
"of",
"the",
"procedure"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
3,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT01228448
|
28:32:cancer,37:41:cancer,47:64:cancer,96:108:treatment
|
Adult subjects with brain, head and neck, and skull base tumors receiving external beam proton radiotherapy at the Francis H. Burr Proton Therapy Center at MGH
| 1
|
[
"Adult",
"subjects",
"with",
"brain",
",",
"head",
"and",
"neck",
",",
"and",
"skull",
"base",
"tumors",
"receiving",
"external",
"beam",
"proton",
"radiotherapy",
"at",
"the",
"Francis",
"H.",
"Burr",
"Proton",
"Therapy",
"Center",
"at",
"MGH"
] |
[
0,
0,
0,
0,
0,
3,
0,
3,
0,
0,
3,
3,
3,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02004275
|
1:9:treatment,15:34:treatment,39:45:treatment
|
Ixazomib is a substrate of CYP3A4 and CYP1A2
| 1
|
[
"Ixazomib",
"is",
"a",
"substrate",
"of",
"CYP3A4",
"and",
"CYP1A2"
] |
[
1,
0,
0,
1,
1,
1,
0,
1
] |
NCT01993810
|
1:38:chronic_disease,61:80:chronic_disease,106:117:cancer,158:171:treatment,
|
Chronic obstructive pulmonary disease exacerbation or other respiratory illness other than the diagnosed lung cancer requiring hospitalization or precluding study therapy within 30 days before registration
| 1
|
[
"Chronic",
"obstructive",
"pulmonary",
"disease",
"exacerbation",
"or",
"other",
"respiratory",
"illness",
"other",
"than",
"the",
"diagnosed",
"lung",
"cancer",
"requiring",
"hospitalization",
"or",
"precluding",
"study",
"therapy",
"within",
"30",
"days",
"before",
"registration"
] |
[
2,
2,
2,
2,
0,
0,
0,
2,
2,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT02122081
|
,,,100:109:treatment
|
Fertile men and women unwilling to use contraceptive techniques during and for 12 months following treatment
| 1
|
[
"Fertile",
"men",
"and",
"women",
"unwilling",
"to",
"use",
"contraceptive",
"techniques",
"during",
"and",
"for",
"12",
"months",
"following",
"treatment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01434316
|
7:19:treatment
|
Prior chemotherapy
| 1
|
[
"Prior",
"chemotherapy"
] |
[
0,
1
] |
NCT02946658
|
1:12:chronic_disease
|
Hepatitis A history
| 1
|
[
"Hepatitis",
"A",
"history"
] |
[
2,
2,
0
] |
NCT02516670
|
24:47:treatment,49:56:treatment,61:106:treatment
|
Are being treated with anticoagulation therapy (aspirin and nonsteroidal anti-inflammatory drugs [NSAIDS] are allowed)
| 1
|
[
"Are",
"being",
"treated",
"with",
"anticoagulation",
"therapy",
"(",
"aspirin",
"and",
"nonsteroidal",
"anti-inflammatory",
"drugs",
"[",
"NSAIDS",
"]",
"are",
"allowed",
")"
] |
[
0,
0,
0,
0,
1,
1,
0,
1,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0
] |
NCT02793921
|
52:78:chronic_disease
|
other symptoms that indicate increased risk for an acute cardiovascular event
| 1
|
[
"other",
"symptoms",
"that",
"indicate",
"increased",
"risk",
"for",
"an",
"acute",
"cardiovascular",
"event"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2
] |
NCT02245841
|
8:27:treatment,32:41:treatment,123:140:chronic_disease
|
Use of topical medications and sunscreen currently and in past will be noted but not weighed for assessment of refractory cutaneous disease
| 1
|
[
"Use",
"of",
"topical",
"medications",
"and",
"sunscreen",
"currently",
"and",
"in",
"past",
"will",
"be",
"noted",
"but",
"not",
"weighed",
"for",
"assessment",
"of",
"refractory",
"cutaneous",
"disease"
] |
[
0,
0,
1,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT02453373
|
14:37:chronic_disease,41:53:treatment,83:95:treatment
|
Suspicion of subarachnoid hemorrhage on pretreatment evaluation, even with normal neuroimaging
| 1
|
[
"Suspicion",
"of",
"subarachnoid",
"hemorrhage",
"on",
"pretreatment",
"evaluation",
",",
"even",
"with",
"normal",
"neuroimaging"
] |
[
0,
0,
2,
2,
0,
1,
0,
0,
0,
0,
0,
1
] |
NCT01799538
|
1:21:chronic_disease
|
Cognitive Impairment
| 1
|
[
"Cognitive",
"Impairment"
] |
[
2,
2
] |
NCT03072238
|
20:58:cancer
|
adequately treated non-melanomatous carcinoma of the skin
| 1
|
[
"adequately",
"treated",
"non-melanomatous",
"carcinoma",
"of",
"the",
"skin"
] |
[
0,
0,
3,
3,
3,
3,
3
] |
NCT02159027
|
10:19:treatment
|
Adequate treatment is defined as meeting the current recommendations of the Centers of Disease Control and Prevention (CDC), National Institutes of Health (NIH) and the HIV Medicine Association of the Infectious Diseases Society of America (IDSA) guidelines33
| 1
|
[
"Adequate",
"treatment",
"is",
"defined",
"as",
"meeting",
"the",
"current",
"recommendations",
"of",
"the",
"Centers",
"of",
"Disease",
"Control",
"and",
"Prevention",
"(",
"CDC",
")",
",",
"National",
"Institutes",
"of",
"Health",
"(",
"NIH",
")",
"and",
"the",
"HIV",
"Medicine",
"Association",
"of",
"the",
"Infectious",
"Diseases",
"Society",
"of",
"America",
"(",
"IDSA",
")",
"guidelines33"
] |
[
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02094118
|
11:35:chronic_disease
|
Prevalent congestive heart failure prior to randomization
| 1
|
[
"Prevalent",
"congestive",
"heart",
"failure",
"prior",
"to",
"randomization"
] |
[
0,
2,
2,
2,
0,
0,
0
] |
NCT02004275
|
56:68:treatment,69:82:treatment,87:97:treatment,101:112:treatment
|
initial response followed by progression on continuous lenalidomide-dexamethasone +/- elotuzumab or daratumumab
| 1
|
[
"initial",
"response",
"followed",
"by",
"progression",
"on",
"continuous",
"lenalidomide-dexamethasone",
"+/-",
"elotuzumab",
"or",
"daratumumab"
] |
[
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1
] |
NCT01415752
|
,,,137:146:treatment
|
Men must agree to use a latex condom during sexual contact with a female of child-bearing potential, even if they have had a successful vasectomy
| 1
|
[
"Men",
"must",
"agree",
"to",
"use",
"a",
"latex",
"condom",
"during",
"sexual",
"contact",
"with",
"a",
"female",
"of",
"child-bearing",
"potential",
",",
"even",
"if",
"they",
"have",
"had",
"a",
"successful",
"vasectomy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01884740
|
,,,144:153:treatment
|
Patients of reproductive age must agree to use a medically effective method of contraception during and for a period of three months after the treatment period
| 1
|
[
"Patients",
"of",
"reproductive",
"age",
"must",
"agree",
"to",
"use",
"a",
"medically",
"effective",
"method",
"of",
"contraception",
"during",
"and",
"for",
"a",
"period",
"of",
"three",
"months",
"after",
"the",
"treatment",
"period"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02495168
|
1:25:treatment
|
Oral (not inhaled) SABAs for 24 hours
| 1
|
[
"Oral",
"(",
"not",
"inhaled",
")",
"SABAs",
"for",
"24",
"hours"
] |
[
1,
1,
1,
1,
0,
0,
0,
0,
0
] |
NCT02911831
|
34:69:cancer
|
Patients with known or suspected endometrial/ovarian/cervical cancer
| 1
|
[
"Patients",
"with",
"known",
"or",
"suspected",
"endometrial/ovarian/cervical",
"cancer"
] |
[
0,
0,
0,
0,
0,
3,
3
] |
NCT01973283
|
25:28:treatment,
|
Currently followed by a PCP (had an eval in last 6-months)
| 1
|
[
"Currently",
"followed",
"by",
"a",
"PCP",
"(",
"had",
"an",
"eval",
"in",
"last",
"6-months",
")"
] |
[
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02885649
|
1:15:cancer
|
Metastatic RCC
| 1
|
[
"Metastatic",
"RCC"
] |
[
3,
3
] |
NCT02186418
|
33:44:treatment
|
Patients who are unable to take hydroxyurea due to financial or safety monitoring constraints
| 1
|
[
"Patients",
"who",
"are",
"unable",
"to",
"take",
"hydroxyurea",
"due",
"to",
"financial",
"or",
"safety",
"monitoring",
"constraints"
] |
[
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT01842399
|
64:91:treatment
|
Unable to perform knee strength testing due to reasons such as bilateral knee replacements
| 1
|
[
"Unable",
"to",
"perform",
"knee",
"strength",
"testing",
"due",
"to",
"reasons",
"such",
"as",
"bilateral",
"knee",
"replacements"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT02915744
|
19:44:chronic_disease
|
Significant known cardiovascular impairment
| 1
|
[
"Significant",
"known",
"cardiovascular",
"impairment"
] |
[
0,
0,
2,
2
] |
NCT01983462
|
1:29:treatment,,,,,,,,
|
Blood chemistries indicative of normal renal (creatinine <2.0 mg/dl), liver (<3 times upper limit for ALT, AST), and thyroid function (TSH between 0.4 - 5.0 mU/L)
| 1
|
[
"Blood",
"chemistries",
"indicative",
"of",
"normal",
"renal",
"(",
"creatinine",
"<",
"2.0",
"mg/dl",
")",
",",
"liver",
"(",
"<",
"3",
"times",
"upper",
"limit",
"for",
"ALT",
",",
"AST",
")",
",",
"and",
"thyroid",
"function",
"(",
"TSH",
"between",
"0.4",
"-",
"5.0",
"mU/L",
")"
] |
[
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02423863
|
1:8:cancer
|
Sarcoma
| 1
|
[
"Sarcoma"
] |
[
3
] |
NCT02610374
|
1:4:chronic_disease
|
HIV-infected cohort (Cohort A)
| 1
|
[
"HIV-infected",
"cohort",
"(",
"Cohort",
"A",
")"
] |
[
2,
0,
0,
0,
0,
0
] |
NCT02531295
|
,,37:40:chronic_disease
|
Pre-ART viral load <2000 copies/ml (HIV controllers)
| 1
|
[
"Pre-ART",
"viral",
"load",
"<",
"2000",
"copies/ml",
"(",
"HIV",
"controllers",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
2,
0,
0
] |
NCT02739035
|
16:22:allergy_name
|
Intolerance to NSAIDs
| 1
|
[
"Intolerance",
"to",
"NSAIDs"
] |
[
0,
0,
4
] |
NCT02860702
|
1:20:chronic_disease,39:53:chronic_disease,55:78:chronic_disease,80:99:chronic_disease
|
Metabolic disorders affecting growth: homocystinuria, methylmalonic acidemias, propionic acidemias, urea cycle defects
| 1
|
[
"Metabolic",
"disorders",
"affecting",
"growth",
":",
"homocystinuria",
",",
"methylmalonic",
"acidemias",
",",
"propionic",
"acidemias",
",",
"urea",
"cycle",
"defects"
] |
[
2,
2,
0,
0,
0,
2,
0,
2,
2,
0,
2,
2,
0,
0,
0,
0
] |
NCT02343549
|
19:38:treatment,
|
Inability to wear NovoTTF-100A System for an average of 18 hours per 24 hours
| 1
|
[
"Inability",
"to",
"wear",
"NovoTTF-100A",
"System",
"for",
"an",
"average",
"of",
"18",
"hours",
"per",
"24",
"hours"
] |
[
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02121158
|
21:44:treatment
|
Stable condition on Optimal Medical Therapy
| 1
|
[
"Stable",
"condition",
"on",
"Optimal",
"Medical",
"Therapy"
] |
[
0,
0,
0,
1,
1,
1
] |
NCT02848417
|
1:17:chronic_disease,23:32:chronic_disease,36:47:chronic_disease
|
Major depression with psychotic or melancholic features
| 1
|
[
"Major",
"depression",
"with",
"psychotic",
"or",
"melancholic",
"features"
] |
[
2,
2,
0,
2,
0,
2,
0
] |
NCT02946892
|
41:95:chronic_disease
|
History or current clinical evidence of moderate-to-severe fixed obstructive pulmonary disease
| 1
|
[
"History",
"or",
"current",
"clinical",
"evidence",
"of",
"moderate-to-severe",
"fixed",
"obstructive",
"pulmonary",
"disease"
] |
[
0,
0,
0,
0,
0,
0,
2,
2,
2,
2,
2
] |
NCT02127658
|
12:20:treatment,
|
who had an incision and drainage of a culture-confirmed MRSA abscess in the Riley Emergency Department or Riley Operating Room within the two weeks prior to enrollment
| 1
|
[
"who",
"had",
"an",
"incision",
"and",
"drainage",
"of",
"a",
"culture-confirmed",
"MRSA",
"abscess",
"in",
"the",
"Riley",
"Emergency",
"Department",
"or",
"Riley",
"Operating",
"Room",
"within",
"the",
"two",
"weeks",
"prior",
"to",
"enrollment"
] |
[
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02762604
|
1:17:chronic_disease,,
|
Terminal illness with life expectancy <12 months
| 1
|
[
"Terminal",
"illness",
"with",
"life",
"expectancy",
"<",
"12",
"months"
] |
[
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02344355
|
25:35:cancer
|
Known active concurrent malignancy, as determined by treating physicians
| 1
|
[
"Known",
"active",
"concurrent",
"malignancy",
",",
"as",
"determined",
"by",
"treating",
"physicians"
] |
[
0,
0,
0,
3,
0,
0,
0,
0,
0,
0
] |
NCT02961114
|
1:16:chronic_disease
|
Severe nocturia
| 1
|
[
"Severe",
"nocturia"
] |
[
2,
2
] |
NCT02960113
|
12:31:chronic_disease,33:41:chronic_disease,45:54:chronic_disease
|
History of open angle glaucoma, seizures or psychosis
| 1
|
[
"History",
"of",
"open",
"angle",
"glaucoma",
",",
"seizures",
"or",
"psychosis"
] |
[
0,
0,
2,
2,
2,
0,
2,
0,
2
] |
NCT03145298
|
1:31:chronic_disease,,
|
Non-pulmonary vascular disease with life expectancy of < 3 years
| 1
|
[
"Non-pulmonary",
"vascular",
"disease",
"with",
"life",
"expectancy",
"of",
"<",
"3",
"years"
] |
[
2,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT00670358
|
10:13:chronic_disease
|
No known HIV positivity
| 1
|
[
"No",
"known",
"HIV",
"positivity"
] |
[
0,
0,
2,
0
] |
NCT02020707
|
27:42:cancer,51:74:cancer,76:90:cancer,102:125:cancer
|
allowable histologies for cervical cancer include squamous cell carcinoma, adenocarcinoma, and mixed/adenosquamous carcinoma
| 1
|
[
"allowable",
"histologies",
"for",
"cervical",
"cancer",
"include",
"squamous",
"cell",
"carcinoma",
",",
"adenocarcinoma",
",",
"and",
"mixed/adenosquamous",
"carcinoma"
] |
[
0,
0,
0,
3,
3,
0,
3,
3,
3,
0,
3,
0,
0,
3,
3
] |
NCT02684201
|
20:30:treatment
|
have an upper-limb amputation
| 1
|
[
"have",
"an",
"upper-limb",
"amputation"
] |
[
0,
0,
0,
1
] |
NCT00862433
|
7:19:chronic_disease
|
Known coagulopathy
| 1
|
[
"Known",
"coagulopathy"
] |
[
0,
2
] |
NCT02169037
|
9:12:treatment
|
in whom PVI has low success and 55 mm baskets are too small for the atria
| 1
|
[
"in",
"whom",
"PVI",
"has",
"low",
"success",
"and",
"55",
"mm",
"baskets",
"are",
"too",
"small",
"for",
"the",
"atria"
] |
[
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02682407
|
33:57:chronic_disease,
|
Have systemic manifestations of Henoch-Schonlein purpura within 2 years prior to Screening
| 1
|
[
"Have",
"systemic",
"manifestations",
"of",
"Henoch-Schonlein",
"purpura",
"within",
"2",
"years",
"prior",
"to",
"Screening"
] |
[
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02572856
|
19:43:treatment
|
Scheduled to have elective general surgery at UW Medical Center
| 1
|
[
"Scheduled",
"to",
"have",
"elective",
"general",
"surgery",
"at",
"UW",
"Medical",
"Center"
] |
[
0,
0,
0,
1,
1,
1,
0,
0,
0,
0
] |
NCT03070535
|
12:20:chronic_disease
|
Be free of dementia, and able to cognitively and physically give informed consent
| 1
|
[
"Be",
"free",
"of",
"dementia",
",",
"and",
"able",
"to",
"cognitively",
"and",
"physically",
"give",
"informed",
"consent"
] |
[
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02650206
|
1:7:treatment,
|
NSAIDs (must cease use 4 weeks prior to study enrollment)
| 1
|
[
"NSAIDs",
"(",
"must",
"cease",
"use",
"4",
"weeks",
"prior",
"to",
"study",
"enrollment",
")"
] |
[
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02947165
|
15:23:chronic_disease,25:49:chronic_disease,51:74:chronic_disease,90:109:treatment,111:120:chronic_disease,135:153:treatment
|
Patients with vitiligo, type I diabetes mellitus, residual hypothyroidism only requiring hormone replacement, psoriasis not requiring systemic treatment, or conditions not expected to recur in the absence of an external trigger
| 1
|
[
"Patients",
"with",
"vitiligo",
",",
"type",
"I",
"diabetes",
"mellitus",
",",
"residual",
"hypothyroidism",
"only",
"requiring",
"hormone",
"replacement",
",",
"psoriasis",
"not",
"requiring",
"systemic",
"treatment",
",",
"or",
"conditions",
"not",
"expected",
"to",
"recur",
"in",
"the",
"absence",
"of",
"an",
"external",
"trigger"
] |
[
0,
0,
2,
0,
2,
2,
2,
2,
0,
2,
2,
0,
0,
1,
1,
0,
2,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02536794
|
57:64:treatment,66:70:treatment,72:95:treatment,97:102:treatment,106:157:treatment
|
including but not limited to cluster of differentiation [CD]137, OX40, programmed death [PD]-1, PD-L1 or cytotoxic T-lymphocyte antigen 4 [CTLA4] inhibitors
| 1
|
[
"including",
"but",
"not",
"limited",
"to",
"cluster",
"of",
"differentiation",
"[",
"CD",
"]",
"137",
",",
"OX40",
",",
"programmed",
"death",
"[",
"PD",
"]",
"-1",
",",
"PD-L1",
"or",
"cytotoxic",
"T-lymphocyte",
"antigen",
"4",
"[",
"CTLA4",
"]",
"inhibitors"
] |
[
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1
] |
NCT02944825
|
1:28:treatment
|
shockwave lithotripsy [SWL]
| 1
|
[
"shockwave",
"lithotripsy",
"[",
"SWL",
"]"
] |
[
1,
1,
1,
0,
0
] |
NCT02252588
|
23:29:chronic_disease,31:45:chronic_disease,47:62:chronic_disease,67:104:chronic_disease
|
Clinical diagnosis of asthma, bronchiectasis, cystic fibrosis, or severe alpha-1 antitrypsin deficiency
| 1
|
[
"Clinical",
"diagnosis",
"of",
"asthma",
",",
"bronchiectasis",
",",
"cystic",
"fibrosis",
",",
"or",
"severe",
"alpha-1",
"antitrypsin",
"deficiency"
] |
[
0,
0,
0,
2,
0,
2,
0,
2,
2,
0,
0,
2,
2,
2,
2
] |
NCT02595866
|
28:35:treatment,,56:71:treatment,92:99:chronic_disease,110:132:treatment,153:162:treatment,167:186:chronic_disease
|
patients who are receiving therapy beyond month one of initial therapy with no evidence of TB IRIS requiring corticosteroid therapy, or those receiving treatment for latent tuberculosis (INH or alternative) may be eligible after discussion with the protocol P.I
| 1
|
[
"patients",
"who",
"are",
"receiving",
"therapy",
"beyond",
"month",
"one",
"of",
"initial",
"therapy",
"with",
"no",
"evidence",
"of",
"TB",
"IRIS",
"requiring",
"corticosteroid",
"therapy",
",",
"or",
"those",
"receiving",
"treatment",
"for",
"latent",
"tuberculosis",
"(",
"INH",
"or",
"alternative",
")",
"may",
"be",
"eligible",
"after",
"discussion",
"with",
"the",
"protocol",
"P.I"
] |
[
0,
0,
0,
0,
1,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
2,
2,
0,
1,
1,
0,
0,
0,
0,
1,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02758847
|
1:13:treatment
|
chemotherapy
| 1
|
[
"chemotherapy"
] |
[
1
] |
NCT02177838
|
1:39:cancer
|
non-melanomatous carcinoma of the skin
| 1
|
[
"non-melanomatous",
"carcinoma",
"of",
"the",
"skin"
] |
[
3,
3,
3,
3,
3
] |
NCT01184547
|
1:10:chronic_disease
|
Cirrhosis
| 1
|
[
"Cirrhosis"
] |
[
2
] |
NCT02355002
|
1:22:treatment
|
deep brain stimulator
| 1
|
[
"deep",
"brain",
"stimulator"
] |
[
1,
1,
1
] |
NCT01389024
|
33:44:allergy_name
|
Known allergy or intolerance of hydroxyurea
| 1
|
[
"Known",
"allergy",
"or",
"intolerance",
"of",
"hydroxyurea"
] |
[
0,
0,
0,
0,
0,
4
] |
NCT02140255
|
14:18:treatment
|
Able to take ARVs by mouth, nasogastric tube, or gastrostomy tube
| 1
|
[
"Able",
"to",
"take",
"ARVs",
"by",
"mouth",
",",
"nasogastric",
"tube",
",",
"or",
"gastrostomy",
"tube"
] |
[
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02518594
|
1:14:chronic_disease,70:86:chronic_disease,175:188:chronic_disease,190:202:chronic_disease,212:236:chronic_disease,,
|
Fetal anomaly in either twin or imminent fetal demise. This includes lethal anomalies, or anomalies that may lead to early delivery or increased risk of neonatal death e.g., gastroschisis, spina bifida, serious karyotypic abnormalities). An ultrasound examination from 14 weeks 0 days to 23 weeks 6 days by project EDC (estimated date of conception) must be performed prior to randomization to evaluate the fetuses for anomalies
| 1
|
[
"Fetal",
"anomaly",
"in",
"either",
"twin",
"or",
"imminent",
"fetal",
"demise",
".",
"This",
"includes",
"lethal",
"anomalies",
",",
"or",
"anomalies",
"that",
"may",
"lead",
"to",
"early",
"delivery",
"or",
"increased",
"risk",
"of",
"neonatal",
"death",
"e.g.",
",",
"gastroschisis",
",",
"spina",
"bifida",
",",
"serious",
"karyotypic",
"abnormalities",
")",
".",
"An",
"ultrasound",
"examination",
"from",
"14",
"weeks",
"0",
"days",
"to",
"23",
"weeks",
"6",
"days",
"by",
"project",
"EDC",
"(",
"estimated",
"date",
"of",
"conception",
")",
"must",
"be",
"performed",
"prior",
"to",
"randomization",
"to",
"evaluate",
"the",
"fetuses",
"for",
"anomalies"
] |
[
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
2,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00719888
|
,,97:109:treatment
|
ligible with (M2 marrow) with =< 25% blasts in marrow after having failed one or more cycles of chemotherapy
| 1
|
[
"ligible",
"with",
"(",
"M2",
"marrow",
")",
"with",
"=",
"<",
"25",
"%",
"blasts",
"in",
"marrow",
"after",
"having",
"failed",
"one",
"or",
"more",
"cycles",
"of",
"chemotherapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT03018704
|
20:32:treatment
|
who have not had a hysterectomy
| 1
|
[
"who",
"have",
"not",
"had",
"a",
"hysterectomy"
] |
[
0,
0,
0,
0,
0,
1
] |
NCT02793375
|
25:36:allergy_name
|
those with allergies to Montelukast and those currently using Montelukast
| 1
|
[
"those",
"with",
"allergies",
"to",
"Montelukast",
"and",
"those",
"currently",
"using",
"Montelukast"
] |
[
0,
0,
0,
0,
4,
0,
0,
0,
0,
0
] |
NCT03078153
|
27:30:chronic_disease
|
Not enrolled in any other HIV prevention trial
| 1
|
[
"Not",
"enrolled",
"in",
"any",
"other",
"HIV",
"prevention",
"trial"
] |
[
0,
0,
0,
0,
0,
2,
0,
0
] |
NCT02527200
|
14:23:treatment
|
No change in treatment plan with growth hormone (GH) from randomisation to the end of the open-label period patients on growth hormone to stay on, patients off GH to stay off during this period. Adjustments in doses of growth hormone will be permitted)
| 1
|
[
"No",
"change",
"in",
"treatment",
"plan",
"with",
"growth",
"hormone",
"(",
"GH",
")",
"from",
"randomisation",
"to",
"the",
"end",
"of",
"the",
"open-label",
"period",
"patients",
"on",
"growth",
"hormone",
"to",
"stay",
"on",
",",
"patients",
"off",
"GH",
"to",
"stay",
"off",
"during",
"this",
"period",
".",
"Adjustments",
"in",
"doses",
"of",
"growth",
"hormone",
"will",
"be",
"permitted",
")"
] |
[
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02702492
|
21:34:treatment,39:48:treatment,61:79:cancer,83:86:cancer
|
Time since the last prior therapy for treatment of advanced solid malignancies or NHL
| 1
|
[
"Time",
"since",
"the",
"last",
"prior",
"therapy",
"for",
"treatment",
"of",
"advanced",
"solid",
"malignancies",
"or",
"NHL"
] |
[
0,
0,
0,
0,
1,
1,
0,
1,
0,
0,
3,
3,
0,
3
] |
NCT01809002
|
1:24:chronic_disease
|
Peripheral Nerve Injury
| 1
|
[
"Peripheral",
"Nerve",
"Injury"
] |
[
2,
2,
2
] |
NCT02214667
|
1:23:chronic_disease
|
bipolar disorder I, II, or NOS
| 1
|
[
"bipolar",
"disorder",
"I",
",",
"II",
",",
"or",
"NOS"
] |
[
2,
2,
2,
2,
0,
0,
0,
0
] |
NCT02859142
|
33:50:allergy_name
|
History of adverse reactions to varenicline (VAR)
| 1
|
[
"History",
"of",
"adverse",
"reactions",
"to",
"varenicline",
"(",
"VAR",
")"
] |
[
0,
0,
0,
0,
0,
4,
4,
0,
0
] |
NCT02379520
|
7:10:chronic_disease
|
Known HIV positivity
| 1
|
[
"Known",
"HIV",
"positivity"
] |
[
0,
2,
0
] |
NCT02844738
|
1:25:treatment,
|
Corticosteroid injection at treatment site within 1 month
| 1
|
[
"Corticosteroid",
"injection",
"at",
"treatment",
"site",
"within",
"1",
"month"
] |
[
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT01584076
|
52:83:allergy_name
|
Known allergies or contraindications to the use of acetylcholinesterase inhibitors
| 1
|
[
"Known",
"allergies",
"or",
"contraindications",
"to",
"the",
"use",
"of",
"acetylcholinesterase",
"inhibitors"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
4,
4
] |
NCT00929006
|
39:49:treatment
|
Restrictions on use of other drugs or treatments
| 1
|
[
"Restrictions",
"on",
"use",
"of",
"other",
"drugs",
"or",
"treatments"
] |
[
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01532687
|
13:27:treatment
|
Implants of levonorgestrel
| 1
|
[
"Implants",
"of",
"levonorgestrel"
] |
[
0,
0,
1
] |
NCT02242110
|
1:24:chronic_disease
|
Intellectual disability
| 1
|
[
"Intellectual",
"disability"
] |
[
2,
2
] |
NCT02484404
|
45:50:treatment,59:84:treatment,114:125:treatment,127:138:treatment,140:149:treatment,151:160:treatment,171:187:treatment
|
Patients are allowed to have received prior PARPi, and/or anti-angiogenesis therapy including but not limited to thalidomide, bevacizumab, sunitinib, sorafenib, or other anti-angiogenics
| 1
|
[
"Patients",
"are",
"allowed",
"to",
"have",
"received",
"prior",
"PARPi",
",",
"and/or",
"anti-angiogenesis",
"therapy",
"including",
"but",
"not",
"limited",
"to",
"thalidomide",
",",
"bevacizumab",
",",
"sunitinib",
",",
"sorafenib",
",",
"or",
"other",
"anti-angiogenics"
] |
[
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
1,
1,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
0,
1,
0,
0,
0,
1
] |
NCT02418195
|
1:12:chronic_disease,
|
Head injury of loss of consciousness in the past 6 months
| 1
|
[
"Head",
"injury",
"of",
"loss",
"of",
"consciousness",
"in",
"the",
"past",
"6",
"months"
] |
[
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01293214
|
17:35:treatment
|
Willing to take immunosuppressants - drugs that help prevent rejection of the transplant - for life
| 1
|
[
"Willing",
"to",
"take",
"immunosuppressants",
"-",
"drugs",
"that",
"help",
"prevent",
"rejection",
"of",
"the",
"transplant",
"-",
"for",
"life"
] |
[
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01920737
|
1:9:cancer
|
Leukemia cell samples will be obtained from all patients enrolled before starting protocol treatment and submitted for Philadelphia chromosome testing by either karyotyping, or for bcr/abl1 translocation by FISH or by PCR for bcr/abl1
| 1
|
[
"Leukemia",
"cell",
"samples",
"will",
"be",
"obtained",
"from",
"all",
"patients",
"enrolled",
"before",
"starting",
"protocol",
"treatment",
"and",
"submitted",
"for",
"Philadelphia",
"chromosome",
"testing",
"by",
"either",
"karyotyping",
",",
"or",
"for",
"bcr/abl1",
"translocation",
"by",
"FISH",
"or",
"by",
"PCR",
"for",
"bcr/abl1"
] |
[
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01989585
|
28:43:treatment,89:119:chronic_disease,154:176:chronic_disease,180:195:treatment
|
Able to swallow and retain oral medication and must not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
| 1
|
[
"Able",
"to",
"swallow",
"and",
"retain",
"oral",
"medication",
"and",
"must",
"not",
"have",
"any",
"clinically",
"significant",
"gastrointestinal",
"abnormalities",
"that",
"may",
"alter",
"absorption",
"such",
"as",
"malabsorption",
"syndrome",
"or",
"major",
"resection",
"of",
"the",
"stomach",
"or",
"bowels"
] |
[
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
2,
2,
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT02050113
|
27:42:allergy_name,44:53:allergy_name,55:68:allergy_name,70:76:allergy_name,92:96:allergy_name,101:108:allergy_name
|
Allergy or sensitivity to stainless steel, polyester, polypropylene, solder (tin, silver), gold, or nitinol
| 1
|
[
"Allergy",
"or",
"sensitivity",
"to",
"stainless",
"steel",
",",
"polyester",
",",
"polypropylene",
",",
"solder",
"(",
"tin",
",",
"silver",
")",
",",
"gold",
",",
"or",
"nitinol"
] |
[
0,
0,
0,
0,
4,
4,
0,
4,
0,
4,
0,
4,
0,
0,
0,
0,
0,
0,
4,
0,
0,
4
] |
NCT02632422
|
29:42:chronic_disease
|
non-progressive etiology of spinal injury
| 1
|
[
"non-progressive",
"etiology",
"of",
"spinal",
"injury"
] |
[
0,
0,
0,
2,
2
] |
NCT02474199
|
11:23:treatment
|
Screening liver biopsy with any of the following histological criteria, as determined by the reading of a central pathologist
| 1
|
[
"Screening",
"liver",
"biopsy",
"with",
"any",
"of",
"the",
"following",
"histological",
"criteria",
",",
"as",
"determined",
"by",
"the",
"reading",
"of",
"a",
"central",
"pathologist"
] |
[
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03182907
|
16:23:treatment
|
has received a vaccine directed against C
| 1
|
[
"has",
"received",
"a",
"vaccine",
"directed",
"against",
"C"
] |
[
0,
0,
0,
1,
0,
0,
0
] |
NCT01901055
|
7:14:chronic_disease,18:37:chronic_disease,41:56:treatment,
|
Acute medical or surgical conditions or hospitalization ≤ 3 months
| 1
|
[
"Acute",
"medical",
"or",
"surgical",
"conditions",
"or",
"hospitalization",
"≤",
"3",
"months"
] |
[
0,
2,
0,
2,
2,
0,
1,
0,
0,
0
] |
NCT01883258
|
12:20:chronic_disease
|
history of diabetes
| 1
|
[
"history",
"of",
"diabetes"
] |
[
0,
0,
2
] |
NCT02332668
|
1:9:cancer
|
Tumor(s) involving the brain stem
| 1
|
[
"Tumor",
"(",
"s",
")",
"involving",
"the",
"brain",
"stem"
] |
[
3,
3,
3,
3,
3,
3,
3,
3
] |
NCT01653093
|
34:50:cancer
|
Patients with known or suspected prostate disease based on clinical data
| 1
|
[
"Patients",
"with",
"known",
"or",
"suspected",
"prostate",
"disease",
"based",
"on",
"clinical",
"data"
] |
[
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0
] |
NCT03114020
|
39:63:treatment,
|
Exacerbation requiring treatment with systemic corticosteroids within the last 3 months
| 1
|
[
"Exacerbation",
"requiring",
"treatment",
"with",
"systemic",
"corticosteroids",
"within",
"the",
"last",
"3",
"months"
] |
[
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT02819635
|
1:16:treatment
|
corticosteroids
| 1
|
[
"corticosteroids"
] |
[
1
] |
NCT02490631
|
12:28:chronic_disease
|
history of spine infections
| 1
|
[
"history",
"of",
"spine",
"infections"
] |
[
0,
0,
2,
2
] |
NCT01766297
|
32:48:cancer
|
Histologic examination showing invasive lobular histology
| 1
|
[
"Histologic",
"examination",
"showing",
"invasive",
"lobular",
"histology"
] |
[
0,
0,
0,
3,
3,
0
] |
NCT02929069
|
1:4:chronic_disease
|
HIV-negative status
| 1
|
[
"HIV-negative",
"status"
] |
[
2,
0
] |
NCT01901562
|
15:27:treatment,
|
Have received chemotherapy in the last 12 months
| 1
|
[
"Have",
"received",
"chemotherapy",
"in",
"the",
"last",
"12",
"months"
] |
[
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT02508038
|
4:23:treatment
|
No supplemental oxygen requirement
| 1
|
[
"No",
"supplemental",
"oxygen",
"requirement"
] |
[
0,
1,
1,
0
] |
NCT03130543
|
63:87:chronic_disease,95:116:chronic_disease,133:149:chronic_disease,157:177:chronic_disease
|
Patients with any pre-existing significant medical diagnosis (congenital heart disease, known neurologic impairment with or without seizure disorder, other congenital anomalies)
| 1
|
[
"Patients",
"with",
"any",
"pre-existing",
"significant",
"medical",
"diagnosis",
"(",
"congenital",
"heart",
"disease",
",",
"known",
"neurologic",
"impairment",
"with",
"or",
"without",
"seizure",
"disorder",
",",
"other",
"congenital",
"anomalies",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
2,
2,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0
] |
NCT01871766
|
29:47:treatment,51:84:treatment,96:104:treatment,151:156:cancer,157:166:treatment
|
Participant has received no prior radiotherapy or chemotherapy for rhabdomyosarcoma (excluding steroids) unless an emergency situation requires local tumor treatment
| 1
|
[
"Participant",
"has",
"received",
"no",
"prior",
"radiotherapy",
"or",
"chemotherapy",
"for",
"rhabdomyosarcoma",
"(",
"excluding",
"steroids",
")",
"unless",
"an",
"emergency",
"situation",
"requires",
"local",
"tumor",
"treatment"
] |
[
0,
0,
0,
0,
1,
1,
0,
1,
1,
1,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
3,
1
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.